Success Story: Senior Software Developer from China Achieves NIW Victory Through Our Assistance

Client’s Testimonial:

“I was amazed by the professionalism and strategic approach of the legal team, which made the complex NIW process feel manageable and clear. Their expert guidance was instrumental in the successful approval of my case, and I am grateful for their invaluable assistance in achieving this goal.”

On March 17^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Senior Software Developer in the Field of Computer Science (Approval Notice).

General Field: Computer Science

Position at the Time of Case Filing: Senior Software Developer

Country of Origin: China

State of Residence at the Time of Filing: New York

Approval Notice Date: March 17^th, 2025

Processing Time: 9 months, 25 days

Case Summary:

Our firm is delighted to announce the successful approval of an I-140 petition under the EB-2 category with a National Interest Waiver (NIW) for an accomplished expert in computer science. The petition was approved in March 2025, validating the national importance and technical merit of the client’s research at the intersection of quantum computing and healthcare.

Our client holds an M.Sc. in computer science and is currently engaged in research and development in the field. His proposed endeavor centers on advancing quantum computing algorithms to efficiently analyze large-scale healthcare data. The goal of this work is to accelerate medical discovery, enhance diagnostic processes, and ultimately improve patient outcomes through better-informed clinical decisions. By addressing bottlenecks in data analysis using state-of-the-art computational methods, his work contributes directly to the innovation and effectiveness of the U.S. healthcare system.

To demonstrate our client’s unique qualifications and the value of his contributions, NAILG submitted a compelling petition with key evidence, including:

Scholarly Output: The client has authored 4 peer-reviewed journal articles and 3 abstracts, reflecting active engagement with the scientific community and a focus on data-intensive medical computing.
Citation Record: His work has been cited 134 times, indicating significant attention and usage from peers in related fields such as medical imaging, bioinformatics, and artificial intelligence in healthcare.
Real-World Application: The petition detailed how his methods are being referenced by researchers working on brain imaging, retinal disease modeling, and cancer diagnosis, showcasing the impact and adaptability of his techniques to diverse biomedical challenges.
Prestigious Funding Sources: His research has been supported by leading institutions such as the National Institutes of Health (NIH), Bright Focus Foundation, and UK Biobank, highlighting its recognized potential for solving complex medical problems.
Policy Alignment: His focus on AI- and quantum-driven solutions for healthcare aligns with U.S. policy goals for technological advancement in medical science and addresses the urgent need for scalable, cost-effective, and accurate healthcare data analytics.

By strategically organizing a petition that addressed all aspects of the Dhanasar framework, substantial merit, national importance, and the client’s ability to advance the endeavor, NAILG successfully obtained a favorable decision from USCIS. This case underscores the growing role of computing innovation in medical breakthroughs and reinforces our client’s contributions to public health and data science.

NAILG is proud to support visionary computer scientists whose work bridges high-performance computing with healthcare, delivering tools and insights that are transforming medicine for the better.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.